Want to join the conversation?
$LYB posted 3Q15 earnings of $1.2Bil, or $2.55 per share, from continuing operations. Excluding lower of cost or market (LCM) adjustment, earnings totaled $1.3Bil, or $2.80 per share, and EBITDA was $2.2Bil. $LYB experienced a transitional period during which markets rebalanced following the decline in supply & price of crude oil in 2Q15.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.